FDA-Inspected Site

AstraZeneca Nijmegen B.V.

7 FDA inspections are on record for AstraZeneca Nijmegen B.V. in Nijmegen, Netherlands.

483· Form 483 issued

Nijmegen, Netherlands · Last updated July 9, 2026

Overview

  • 7 FDA inspections are on record.
  • 6 inspections produced a Form 483.
  • The most recent recorded inspection date is 2019-09-19.

At a glance

Inspections

7

Form 483s

6

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
12 Sep 2019 – 19 Sep 2019Human Drugs483On file
9 Sep 2019 – 10 Sep 2019Human DrugsClean
14 Sep 2017 – 22 Sep 2017Human Drugs483On file
28 May 2015 – 5 Jun 2015Human Drugs483View 483 →
13 Jun 2013 – 21 Jun 2013Human Drugs483On file
27 Sep 2011Not recorded483On file
23 Oct 2008Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

5 Jun 2015
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by April L Young

5 Jun 2015
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by April L Young

5 Jun 2015
21 CFR 211.160(b)(1)

Sampling and testing procedures described

Cited by April L Young

5 Jun 2015
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by April L Young

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind AstraZeneca Nijmegen B.V.'s 6 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat